Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients.
The 5th annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes and analyzes the first 6 years of patient and data collection. The current analysis includes more than 6000 patients and updated risk factors for continuous flow pumps. Among continuous flow pumps, actuarial survival is 80% at 1 year and 70% at 2 years. Quality of life indicators are generally favorable and adverse event burden will likely influence patient selections of advanced heart failure therapies.
University of Alabama at Birmingham, Birmingham, Alabama, USA. jkirklin@uab.edu
James K
JK
Kirklin
David C
DC
Naftel
Robert L
RL
Kormos
Lynne W
LW
Stevenson
Francis D
FD
Pagani
Marissa A
MA
Miller
J T
JT
Baldwin
J
J
Timothy Baldwin
James B
JB
Young
D000328:Adult; D000847:Annual Reports as Topic; D001243:Assisted Circulation / Q000295:instrumentation*; D004867:Equipment Design; D006333:Heart Failure / Q000150:complications / Q000628:therapy*; D006353:Heart-Assist Devices / Q000706:statistics & numerical data; D006801:Humans; D009316:National Institutes of Health (U.S.); D011788:Quality of Life; D012042:Registries; D051437:Renal Insufficiency / Q000150:complications; D012307:Risk Factors; D014481:United States; D018497:Ventricular Dysfunction, Right / Q000150:complications